TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/21/24 19:17 | 6/21/24 | DAWN | Day One Biopharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ramasastry Saira | CA | D | S | -132 | 13.19 | 0 | -10 | -20 | 40 | D | |||||||||||||||
6/12/24 12:21 | 6/11/24 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ramasastry Saira | CA | D | S | -44 | 10.95 | 0 | -4 | -21 | 15 | D | |||||||||||||||
6/7/24 18:20 | 6/5/24 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ramasastry Saira | CA | D | S.d | -128 | 25.68 | 0 | -5 | -100 | 0 | D | |||||||||||||||
6/2/23 12:19 | 6/1/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ramasastry Saira | CA | D | S | -90 | 25.67 | 0 | -4 | -25 | 11 | D | |||||||||||||||
7/13/22 16:05 | 7/11/22 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ramasastry Saira | CA | D | S.d | -150 | 30.00 | 0 | -5 | -38 | 8 | D | |||||||||||||||
5/25/22 17:49 | 5/24/22 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ramasastry Saira | CA | D | S.d | -40 | 23.82 | 0 | -2 | -17 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |